Latest AI and machine learning research in skin cancer for healthcare professionals.
Uveal melanoma (UVM) is the most common primary intraocular human malignancy with a high mortality r...
The accurate quantification of tumor-infiltrating immune cells turns crucial to uncover their role i...
In recent clinical practice the molecular diagnostics have been significantly empowered and upgraded...
BACKGROUND: Currently, only a fraction of patients with non-small cell lung cancer (NSCLC) treated w...
A reported 96,480 people were diagnosed with melanoma in the United States in 2019, leading to 7230 ...
BACKGROUND: Cutaneous warts are common benign skin lesions caused by human papillomavirus. Various t...
Giant molluscum contagiosum (MC) is a peculiar variant of the disease with the presence of multiple ...
IMPORTANCE: Less than 10% of patients with cancer have detectable pathogenic germline alterations, w...
Dacarbazine (DTIC) is a first-line chemotherapy drug that is widely used in clinical practice for ma...
SIGNIFICANCE: Melanoma is a deadly cancer that physicians struggle to diagnose early because they la...
Immune checkpoint inhibitors (ICIs) have revolutionized the therapeutic landscape of gastrointestina...
The structural design parameters of a medical microrobot, such as the morphology and surface chemist...
Here, a model-free controller for cancer treatment is presented. The treatment objective is to find ...
INTRODUCTION: Cutaneous warts caused by human papillomavirus are the most common dermatological dise...
PURPOSE: Medical records contain a wealth of useful, informative data points valuable for clinical r...
OBJECTIVE: Prognosis of patients with metastatic melanoma has dramatically improved over recent year...
We propose an approach based on a convolutional neural network to classify skin lesions using the re...
INTRODUCTION: Immunotherapy is regarded as one of the major breakthroughs in cancer treatment. Despi...
BACKGROUND: Cytokine-induced killer (CIK) cells and natural killer (NK) cells are employed by two di...